Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): A randomized prospective trial to compare intra and early postoperative outcomes. 2017

G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
Departamento de Urología, Humanitas Mater Domini, Castellanza, Italia. Electronic address: gioboz@yahoo.it.

OBJECTIVE To compare clinical intra and early postoperative outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and transurethral bipolar resection of the prostate (TURis) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial. METHODS The study randomized 208 consecutive patients with BPH to ThuLEP (n=102) or TURis (n=106). For all patients were evaluated preoperatively with regards to blood loss, catheterization time, irrigation volume, hospital stay and operative time. At 3 months after surgery they were also evaluated by International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), and postvoid residual urine volume (PVR). RESULTS The patients in each study arm each showed no significant difference in preoperative parameters. Compared with TURIS, ThuLEP had same operative time (53.69±31.44 vs 61.66±18.70minutes, P=.123) but resulted in less hemoglobin decrease (0.45 vs 2.83g/dL, P=.005). ThuLEP also needed less catheterization time (1.3 vs 4.8 days, P=.011), irrigation volume (29.4 vs 69.2 L, P=.002), and hospital stay (1.7 vs 5.2 days, P=.016). During the 3 months of follow-up, the procedures did not demonstrate a significant difference in Qmax, IPSS, PVR, and QOLS. CONCLUSIONS ThuLEP and TURis both relieve lower urinary tract symptoms equally, with high efficacy and safety. ThuLEP was statistically superior to TURis in blood loss, catheterization time, irrigation volume, and hospital stay. However, procedures did not differ significantly in Qmax, IPSS, PVR, and QOLS through 3 months of follow-up.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D013932 Thulium An element of the rare earth family of metals. It has the atomic symbol Tm, atomic number 69, and atomic weight 168.93.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
July 2008, Indian journal of urology : IJU : journal of the Urological Society of India,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
February 2008, European urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
July 2021, World journal of urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
February 2008, European urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
May 2019, World journal of urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
August 2007, European urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
September 2004, The Journal of urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
February 2013, Urology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
July 2014, International urology and nephrology,
G Bozzini, and M Seveso, and S Melegari, and O de Francesco, and N M Buffi, and G Guazzoni, and M Provenzano, and A Mandressi, and G Taverna
June 2021, World journal of urology,
Copied contents to your clipboard!